Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | FAAH | O00519 | 2/20 | 0.46 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.46 |
| ▸ | ARG2 | P78540 | 7/20 | 0.44 |
| ▸ | ARG1 | P05089 | 6/20 | 0.44 |
| ▸ | ACLY | P53396 | 1/20 | 0.41 |
| ▸ | EP300 | Q09472 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28798096 | 0.89 | ARG2 (0.42) | TSHRFAAHTRPV1ARG2ARG1 | |
| SCHEMBL7085625 | 0.88 | ARG2 (0.45) | TSHRFAAHTRPV1ARG2ARG1 | |
| SCHEMBL16887806 | 0.85 | ARG2 (0.52) | ARG2ARG1MEN1ALDH1A1CYP1A2 | |
| SCHEMBL11414745 | 0.85 | ARG2 (0.52) | ARG2ARG1MEN1ALDH1A1CYP1A2 | |
| SCHEMBL5613147 | 0.84 | TERT (0.55) | FAAHACLYMEN1CYP1A2KMT2A | |
| SCHEMBL3024369 | 0.83 | ARG2 (0.53) | ARG2ARG1MEN1ALDH1A1CYP1A2 | |
| SCHEMBL6129347 | 0.83 | ARG2 (0.53) | ARG2ARG1MEN1ALDH1A1CYP1A2 | |
| SCHEMBL14088071 | 0.83 | ARG2 (0.53) | ARG2ARG1MEN1ALDH1A1CYP1A2 | |
| SCHEMBL8719171 | 0.83 | ARG2 (0.53) | ARG2ARG1MEN1ALDH1A1CYP1A2 | |
| SCHEMBL31586115 | 0.83 | ARG2 (0.53) | ARG2ARG1MEN1ALDH1A1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4489855-A1 | ANTI-GLP1R ANTIBODY-DRUG CONJUGATES COMPRISING GLP1 PEPTIDOMIMETICS AND USES THEREOF | Regeneron Pharmaceuticals, Inc. (US) | 2025-01-15 | — | — | EP | disclosed |
| WO-2022090448-A1 | NOVEL ACYLATING REAGENTS | NOVO NORDISK A/S (DK) | 2022-05-05 | — | — | WO | disclosed |